MDV3100 News (3 articles)
|
|
New Targeted Therapy Effective in Treating Advanced Prostate CancerNEW YORK, NY - An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC), known... Published on 15 April 2010, 05:51 |
|
New Drug for Advanced Prostate Cancer Shows PromiseOHSU Knight Cancer Institute is one of four centers worldwide to evaluate the new compoundA new drug called MDV3100 has shown significant promise in lowering the prostate specific antigen (PSA) levels ‑ a marker for tumor growth ‑ in men with advanced prostate cancer who have no other option... Published on 16 April 2009, 10:50 |
|
New drug shows promise in treating drug-resistant prostate cancerA new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs. Chemists and biologists at UCLA and colleagues at several other institutions, including Memorial Sloan-Kettering Cancer... Published on 9 April 2009, 19:51 |
|
|
Top Categories
We have launched our peer- reviewed, Open-access journal: Insciences Journal
Recently added
27.11.12
Consequential Life Cycle Assessment of Nitrogen Fertilisers Based on Biomass – a Swedish perspective
08.11.12
From Molecular Hollows to Imprinting Strategies – Mass-Sensitive Devices in Host-Guest Chemistry
26.04.12
CdSe/ZnSe Quantum-Dot Semiconductor Optical Amplifiers
23.03.12
Screen-printed Electrochemical Sensors and Biosensors for Monitoring Metal Pollutants